SNAP-8 For Lab Research

Buy SNAP-8 Peptide UK – >99% Purity | Acetyl Octapeptide-3 | Research Use Only

SNAP-8 (Acetyl Octapeptide-3) is a synthetic 8-amino acid neuropeptide and enhanced analog of Argireline, studied as a competitive SNARE complex inhibitor and one of the most well-characterised neuromuscular modulation peptides in cosmetic and dermatological research. Buy SNAP-8 peptide in the UK from Peptides Lab UK with >99% HPLC-verified purity, batch-specific COA, and fast UK dispatch for laboratory and in-vitro research use only.

What is SNAP-8 Peptide?

SNAP-8, also known by its INCI name Acetyl Octapeptide-3, is a synthetic peptide composed of eight amino acids with the sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂. It was originally developed by Lipotec (Barcelona, Spain) in the early 2000s as an extended and improved version of Argireline (Acetyl Hexapeptide-3), which itself was developed as a topical research analog to study the same neuromuscular pathway as botulinum toxin.

The two additional amino acids added to Argireline’s sequence — alanine and aspartate — confer greater stability against enzymatic degradation and enhance the peptide’s affinity for its target site within the SNARE complex, making it approximately 30% more active than its parent compound in both in-vitro and in-vivo studies.

SNAP-8 is now one of the most widely referenced peptides in cosmeceutical and dermatological research, and a key tool for laboratories investigating neuromuscular modulation, peptide delivery systems, and wrinkle formation mechanisms.

Product Specifications:

Parameter	Specification
INCI Name	Acetyl Octapeptide-3
Sequence	Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂
Purity	>99% (HPLC verified)
Form	Lyophilised powder
Molecular Weight	~1,075 g/mol
Storage	–20°C, protect from light and moisture
Solubility	Sterile water, PBS, or suitable research-grade solvents

What is the SNARE Complex, and Why Does It Matter in Research?

To understand how SNAP-8 works, it helps to understand the SNARE complex — the molecular machinery at the core of SNAP-8’s mechanism and the reason it is so widely studied.

The SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex is a group of proteins — including SNAP-25, syntaxin, and synaptobrevin — that mediate the fusion of neurotransmitter-containing vesicles with the cell membrane at neuromuscular junctions. When this complex assembles, it triggers the release of acetylcholine, causing muscle contraction.

SNAP-25 (Synaptosomal-Associated Protein 25) is the natural protein component of this complex that gives SNAP-8 its name — the peptide is a mimic of SNAP-25’s N-terminal domain. By occupying SNAP-25’s binding site within the SNARE complex, SNAP-8 competes for and partially destabilises complex assembly, reducing acetylcholine release and attenuating muscle contraction at the neuromuscular junction in research models.

This is the same pathway studied in the context of botulinum toxin research — the key difference being that botulinum toxin cleaves SNAP-25 irreversibly, while SNAP-8 acts through competitive, reversible inhibition, making it a more tractable research tool for controlled in-vitro and ex-vivo studies.

How Does SNAP-8 Work?

SNAP-8 functions as a competitive inhibitor of SNARE complex formation through the following mechanism:

• SNAP-25 mimicry — SNAP-8 structurally mimics the N-terminal end of SNAP-25, the key protein mediating vesicle-membrane fusion at neuromuscular junctions
• Competitive SNARE binding — SNAP-8 competes with endogenous SNAP-25 for the binding sites on syntaxin and synaptobrevin within the SNARE complex
• SNARE complex destabilisation — partial destabilisation of the assembled SNARE complex reduces the efficiency of neurotransmitter vesicle fusion with the membrane
• Acetylcholine release inhibition — reduced SNARE complex efficiency attenuates acetylcholine release at nerve endings
• Muscle contraction attenuation — reduced acetylcholine signalling decreases the intensity of facial muscle contractions associated with dynamic expression line formation
• Reversibility — unlike botulinum toxin, SNAP-8’s inhibition is competitive and reversible, making it suitable for controlled, repeatable experimental protocols

The N-terminal acetylation and C-terminal amidation of SNAP-8’s structure protect against enzymatic degradation and enhance peptide integrity in experimental environments, improving its utility as a research compound compared to unmodified peptide analogs.

What Does SNAP-8 Do in Research?

In pre-clinical, in-vitro, and ex-vivo laboratory models, SNAP-8 has been studied across a range of applications in dermatological, cosmeceutical, and neurobiological research:

• Dynamic wrinkle formation models — in-vitro studies have demonstrated SNAP-8 can reduce wrinkle depth by up to 63% by attenuating muscle contractions associated with facial expression lines
• Periorbital region studies — clinical evaluations have specifically reported wrinkle severity around the eyes reduced by up to 63.13% in SNAP-8 formulation studies
• Comparative neuromodulator research — SNAP-8 is approximately 30% more active than Argireline in both in-vitro and in-vivo efficacy testing, making it a preferred comparator in SNARE-targeted peptide studies
• Expression line and forehead wrinkle models — research has examined SNAP-8’s efficacy specifically for dynamic wrinkles of the glabellar region and forehead
• Peptide delivery system research — SNAP-8 has been used to evaluate novel transdermal delivery technologies including biodegradable microneedle patches, nanoparticle-based controlled release systems, and liposomal carriers
• Multi-peptide combination studies — SNAP-8 is frequently studied in combination with collagen-stimulating peptides such as GHK-Cu, Matrixyl (Palmitoyl Pentapeptide-4), and Leuphasyl for synergistic dermal outcome research
• Peptide serum formulation studies — a 2022 study evaluated a multi-peptide facial serum including SNAP-8 in skin explants and a 12-week clinical trial in women aged 35–55, reporting significant improvements in skin smoothness, wrinkle reduction, epidermal thickness, and skin hydration
• Synaptic transmission and neuromuscular junction models — beyond dermatology, SNAP-8 is studied as a research tool for investigating SNARE-mediated neurotransmitter release and vesicle exocytosis in broader neurobiological research models

What Do Studies Say About SNAP-8 Peptide?

SNAP-8 has a well-established body of peer-reviewed cosmetic and analytical research literature:

• Ji M et al. (2020) — Journal of Analytical Science and Technology, 11, Article 34 — Foundational analytical study confirming SNAP-8 (Acetyl Octapeptide-3) as more effective than Acetyl Hexapeptide-3 and more stable than botulinum toxin for wrinkle relief. Developed and validated an LC-MS/MS method for SNAP-8 quantification in cosmetic formulations including biodegradable microneedle patches, confirming linearity, precision, and sensitivity at sub-nanogram levels. DOI: 10.1186/s40543-020-00232-8
• Moy M et al. (2023) — Journal of Cosmetic Dermatology, 22(1): 267–274 — Evaluated a Peptide-Pro Complex serum containing SNAP-8 and several other peptides on aged skin. Demonstrated significant improvements in wrinkle depth, skin smoothness, and skin texture across the study period.
• Baglamis S et al. (2023) — Polymer Bulletin, 80(12): 12659–12681 — Investigated the use of nanoparticle systems for controlled release of SNAP-8 in anti-wrinkle research applications. Results confirmed the nanoparticle delivery system provided improved stability and controlled release kinetics, presenting a promising strategy for boosting peptide delivery efficiency in research formulations.
• Nguyen TTM (2024) — Cosmetics, 11(4): 118 — Reviewed non-invasive peptides as alternatives in wrinkle modulation research, placing SNAP-8 within the broader class of SNARE-targeting peptides and confirming its mechanism relative to botulinum toxin and Argireline.
• Badilli U & Inal Ö (2025) — Current Approaches in Cosmeceuticals: Peptides, Biotics and Marine Biopolymers — Comprehensive 2025 review covering SNAP-8 within the current cosmeceutical peptide landscape, confirming its role in collagen synthesis promotion, skin cell proliferation modulation, and SNARE-mediated expression line research.
• Lipotec In-Vivo Clinical Data — Clinical evaluations of SNAP-8 formulations confirm: 21% reduction in wrinkle depth after 7 days of application; 38% reduction after 28 days; up to 63.13% reduction in periorbital wrinkle severity in extended treatment studies.Note: All cited research relates to in-vitro, ex-vivo, and cosmetic clinical formulation studies. SNAP-8 is supplied by Peptides Lab UK for laboratory research use only and is not approved for any standalone therapeutic or human medicinal use.

What is SNAP-8 Used For in Research?

Researchers purchasing SNAP-8 from UK peptides suppliers like Peptides Lab UK typically focus on:

• SNARE complex inhibition and neuromuscular modulation studies
• Dynamic wrinkle formation and expression line mechanism research
• Transdermal and intradermal peptide delivery system development (microneedles, nanoparticles, liposomes)
• Comparative SNARE-targeting peptide studies alongside Argireline, Leuphasyl, and SYN-AKE
• Multi-peptide serum and cosmeceutical formulation research
• Neurotransmitter release and acetylcholine vesicle exocytosis models
• Peptide stability and degradation kinetics studies
• Synaptic transmission and vesicle fusion research in broader neurobiological models
• Analytical method development for cosmetic peptide quantification (HPLC, LC-MS/MS)

SNAP-8 vs Argireline vs Botulinum Toxin – Research Comparison

Feature	SNAP-8	Argireline	Botulinum Toxin
Amino Acids	8	6	N/A (protein)
Mechanism	Competitive SNARE inhibition	Competitive SNARE inhibition	Irreversible SNAP-25 cleavage
Potency vs Argireline	~30% more active	Baseline	Significantly higher
Reversibility	Yes	Yes	No
Stability	Enhanced (acetylated/amidated)	Good	Variable
Research Utility	Preferred peptide analog	Established comparator	Reference compound
Administration	Topical/in-vitro	Topical/in-vitro	Injection

SNAP-8’s reversibility and improved stability make it the preferred research tool for controlled, repeatable SNARE pathway studies over irreversible neuromodulators.

Quality & Purity Assurance

Every batch of SNAP-8 from Peptides Lab UK is:

• >99% pure — HPLC and mass spectrometry verified
• Supplied with a full Certificate of Analysis (COA) on request
• Lyophilised powder for maximum stability and long shelf life
• Manufactured under strict, controlled laboratory conditions
• Consistent batch-to-batch quality for reproducible research results

Why Buy SNAP-8 from Peptides Lab UK?

When you buy SNAP-8 peptide UK from Peptides Lab UK, you receive:

99% purity, HPLC and MS verified, third-party tested

• Full COA documentation per batch
• Fast same-day UK dispatch with tracked delivery
• Competitive pricing with bulk research discounts available
• Trusted by researchers across the UK and Europe

Research Disclaimer: All products supplied by Peptides Lab UK are intended strictly for in-vitro laboratory research and scientific study use only. They are not intended for human consumption, veterinary use, or any medical or therapeutic application. SNAP-8 (Acetyl Octapeptide-3) as supplied has not been evaluated by the MHRA or any regulatory authority for safety or efficacy as a standalone compound in humans or animals. All research citations on this page relate to cosmetic formulation studies, in-vitro data, and analytical research, and do not constitute evidence of safety or therapeutic efficacy of the raw peptide. Peptides Lab UK accepts no liability for any misuse of research compounds. By purchasing, you confirm that you are a qualified researcher and that the product will be used solely within a controlled laboratory environment in compliance with all applicable UK laws, regulations, and institutional guidelines.